BRAF and interstitial lung disease: Novel primary malignancies, tumor promotion in BRAF wild-type patients, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, interstitial lung disease, skin toxicity, febrile reactions, hyperglycemia115